{"id":11128,"date":"2026-10-17T12:10:57","date_gmt":"2026-10-17T11:10:57","guid":{"rendered":"https:\/\/www.ilmelanoma.com\/?page_id=11128"},"modified":"2026-10-17T12:10:57","modified_gmt":"2026-10-17T11:10:57","slug":"melanoma-astrocytoma-syndrome","status":"publish","type":"page","link":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/","title":{"rendered":"Melanoma\u2013astrocytoma syndrome"},"content":{"rendered":"<div class=\"im26-diagnosis-guide im26-care-guide\">\n<p class=\"im26-care-intro\">A rare predisposition requiring clinical genetics and individualised surveillance.<\/p>\n<nav class=\"im26-dg-toc\" aria-label=\"On this page\"><strong>On this page<\/strong><\/p>\n<ol>\n<li><a href=\"#care-significato\">A rare syndrome, not a count of 200,000 cases<\/a><\/li>\n<li><a href=\"#care-valutazione\">From family history to diagnosis<\/a><\/li>\n<li><a href=\"#care-controlli\">Surveillance and limits of knowledge<\/a><\/li>\n<\/ol>\n<\/nav>\n<section class=\"im26-dg-section\" id=\"care-significato\">\n<h2>A rare syndrome, not a count of 200,000 cases<\/h2>\n<p>Melanoma\u2013astrocytoma syndrome describes families in which susceptibility to melanoma and nervous system tumours, particularly gliomas or astrocytomas, may occur together. It falls within some CDKN2A-related predisposition patterns, especially alterations affecting p14ARF. The name does not mean that everyone with melanoma will develop a brain tumour.<\/p>\n<p>The figure of 200,000 people in the historical page misread the US threshold used to define a rare disease as a count of people with this syndrome. It was not a prevalence estimate. No reliable population figure is offered here to replace it. Reported families are rare and risks depend on the variant and clinical context.<\/p>\n<p>Inherited susceptibility to different primary tumours must be distinguished from brain metastases of melanoma: these are different biological and clinical problems. An astrocytoma in one relative does not by itself establish the syndrome, and melanoma brain metastases do not demonstrate inherited susceptibility.<\/p>\n<div class=\"im26-dg-gallery im26-care-images\">\n<figure><a href=\"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg\"><img loading=\"lazy\" src=\"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg\" width=\"300\" height=\"208\" loading=\"lazy\" decoding=\"async\" alt=\"Image retained from the site archive.\"\/><\/a><figcaption>Image retained from the site archive.<\/figcaption><\/figure>\n<\/div>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK616232\/\">GeneReviews \u2014 CDKN2A Cancer Predisposition, 2025<\/a>; <a href=\"https:\/\/medlineplus.gov\/genetics\/gene\/cdkn2a\/\">MedlinePlus Genetics \u2014 CDKN2A<\/a>.<\/small><\/p>\n<\/section>\n<section class=\"im26-dg-section\" id=\"care-valutazione\">\n<h2>From family history to diagnosis<\/h2>\n<p>Suspicion arises from documented family diagnoses, age at onset, multiple melanomas and other clinical features. Reports should be reviewed: a phrase such as \u201cbrain cancer\u201d can refer to different conditions. Neurofibromas, schwannomas, meningiomas and other tumours described in individual historical families are not a mandatory diagnostic checklist.<\/p>\n<p><a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/\">Genetic counselling<\/a> determines whether germline CDKN2A testing or a broader panel is appropriate. Deletions may require methods additional to sequencing; the laboratory and geneticist select the analysis. A variant detected only in tumour tissue must be interpreted before inferring risk in relatives.<\/p>\n<p>If a familial pathogenic variant is identified, targeted testing can be discussed with blood relatives. Consent and communication must respect individual choices. An uncertain result does not justify labelling the entire family as affected. A negative result also requires explanation when the <a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/\">family history<\/a> remains suggestive.<\/p>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK616232\/\">GeneReviews \u2014 CDKN2A Cancer Predisposition, 2025<\/a>.<\/small><\/p>\n<\/section>\n<section class=\"im26-dg-section\" id=\"care-controlli\">\n<h2>Surveillance and limits of knowledge<\/h2>\n<p>The plan includes skin surveillance and, depending on the variant and history, assessment of other organs. GeneReviews notes that annual brain and whole-body MRI may be considered for variants affecting p14ARF when there is a <a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/\">family history<\/a> of nervous system tumours. This is an expert-centre decision, not screening for every relative of anyone with melanoma.<\/p>\n<p>UV prevention, attention to new lesions and dermatological <a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/\">follow-up<\/a> remain essential. New neurological symptoms require clinical assessment regardless of the schedule; sudden serious symptoms require urgent care. Any pancreatic surveillance should be coordinated within the CDKN2A pathway to avoid duplication.<\/p>\n<p>The outlook for an established tumour depends on its site, type, biological features and stage, not simply the syndrome\u2019s name. Historical family reports contributed to discovering this predisposition but do not provide reliable individual percentages. Ask the geneticist for a written plan, a specialist contact and a timetable for reconsidering variant classification rather than an indiscriminate list of investigations.<\/p>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK616232\/\">GeneReviews \u2014 CDKN2A Cancer Predisposition, 2025<\/a>.<\/small><\/p>\n<\/section>\n<aside class=\"im26-dg-related\">\n<h2>Continue the pathway<\/h2>\n<div class=\"im26-resource-grid\">\n<article>\n<h3><a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/\">Familial melanoma: genetics and surveillance<\/a><\/h3>\n<p>When family history warrants genetic counselling and what testing can clarify.<\/p>\n<\/article>\n<article>\n<h3><a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/\">After melanoma: follow-up and everyday life<\/a><\/h3>\n<p>A personalised plan for surveillance, symptoms, recovery and support after diagnosis.<\/p>\n<\/article>\n<\/div>\n<\/aside>\n<p class=\"im26-dg-sources\"><small>Editorial review and source consultation: 17 October 2026. Educational information, not individual healthcare or benefits advice. Source checking does not certify a new specialist clinical validation.<\/small><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A rare predisposition requiring clinical genetics and individualised surveillance.<\/p>\n","protected":false},"author":13,"featured_media":0,"parent":6483,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-11128","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Melanoma\u2013astrocytoma syndrome - Il Melanoma<\/title>\n<meta name=\"description\" content=\"A rare predisposition requiring clinical genetics and individualised surveillance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanoma\u2013astrocytoma syndrome - Il Melanoma\" \/>\n<meta property=\"og:description\" content=\"A rare predisposition requiring clinical genetics and individualised surveillance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"Il Melanoma\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/\",\"name\":\"Melanoma\u2013astrocytoma syndrome - Il Melanoma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDKN2AFig2-300x208.jpg\",\"datePublished\":\"2026-10-17T11:10:57+00:00\",\"description\":\"A rare predisposition requiring clinical genetics and individualised surveillance.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDKN2AFig2-300x208.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDKN2AFig2-300x208.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/melanoma-astrocytoma-syndrome\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Melanoma and &#8230;..\",\"item\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Familial malignant melanoma\",\"item\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma-and-2\\\/familial-malignant-melanoma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Melanoma\u2013astrocytoma syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/\",\"name\":\"Il Melanoma\",\"description\":\"la guida alla conoscenza, prevenzione e cura del melanoma\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#organization\",\"name\":\"Il Melanoma\",\"alternateName\":\"ilmelanoma.com\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo-melanoma-azzurro.png\",\"contentUrl\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo-melanoma-azzurro.png\",\"width\":300,\"height\":29,\"caption\":\"Il Melanoma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Melanoma\u2013astrocytoma syndrome - Il Melanoma","description":"A rare predisposition requiring clinical genetics and individualised surveillance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Melanoma\u2013astrocytoma syndrome - Il Melanoma","og_description":"A rare predisposition requiring clinical genetics and individualised surveillance.","og_url":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/","og_site_name":"Il Melanoma","og_image":[{"url":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/","url":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/","name":"Melanoma\u2013astrocytoma syndrome - Il Melanoma","isPartOf":{"@id":"https:\/\/www.ilmelanoma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/#primaryimage"},"image":{"@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg","datePublished":"2026-10-17T11:10:57+00:00","description":"A rare predisposition requiring clinical genetics and individualised surveillance.","breadcrumb":{"@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/#primaryimage","url":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg","contentUrl":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2012\/02\/CDKN2AFig2-300x208.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/melanoma-astrocytoma-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Melanoma and &#8230;..","item":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/"},{"@type":"ListItem","position":2,"name":"Familial malignant melanoma","item":"https:\/\/www.ilmelanoma.com\/en\/melanoma-and-2\/familial-malignant-melanoma\/"},{"@type":"ListItem","position":3,"name":"Melanoma\u2013astrocytoma syndrome"}]},{"@type":"WebSite","@id":"https:\/\/www.ilmelanoma.com\/en\/#website","url":"https:\/\/www.ilmelanoma.com\/en\/","name":"Il Melanoma","description":"la guida alla conoscenza, prevenzione e cura del melanoma","publisher":{"@id":"https:\/\/www.ilmelanoma.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ilmelanoma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ilmelanoma.com\/en\/#organization","name":"Il Melanoma","alternateName":"ilmelanoma.com","url":"https:\/\/www.ilmelanoma.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ilmelanoma.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2023\/06\/logo-melanoma-azzurro.png","contentUrl":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2023\/06\/logo-melanoma-azzurro.png","width":300,"height":29,"caption":"Il Melanoma"},"image":{"@id":"https:\/\/www.ilmelanoma.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/11128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/comments?post=11128"}],"version-history":[{"count":1,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/11128\/revisions"}],"predecessor-version":[{"id":11135,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/11128\/revisions\/11135"}],"up":[{"embeddable":true,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/6483"}],"wp:attachment":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/media?parent=11128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}